Company intelligence / Profile preview
Vial
San Francisco, California, United Statesvial.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Vial operates as a next-generation biotech and tech-enabled CRO. It advances a pipeline of biologics and RNA therapeutics using a computational discovery engine to design differentiated drug candidates at scale. Its lead asset, TL1A HLE for inflammatory bowel disease, entered Phase I in early/mid‑2025 with interim data expected in Q3–Q4 2025. Other programs are preclinical with planned INDs or Phase I starts in late 2025. The company also provides highly automated clinical trial services to external sponsors using proprietary digital platforms.
- Therapeutic areas
- PulmonologyEndocrinologyDermatologyGastroenterologyInfectious Diseases
- Modalities
- BiologicRNA therapySmall moleculeMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Nielsen BioSciences – partnered on a Phase III trial for CANDIN® in common warts as the contract research organization partner.
Beyond the preview
Go deeper on Vial.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vial.